{"id":"NCT00313209","sponsor":"AstraZeneca","briefTitle":"Effect of Roflumilast on Lung Function in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Salmeterol: The EOS Study (BY217/M2-127)","officialTitle":"Effect of Roflumilast in COPD Patients Treated With Salmeterol. A 24-week, Double-blind Study With 500 Î¼g Roflumilast Once Daily Versus Placebo. The EOS Study","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-04","primaryCompletion":"2007-07","completion":"2008-02","firstPosted":"2006-04-12","resultsPosted":"2011-05-19","lastUpdate":"2016-12-14"},"enrollment":933,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Obstructive Pulmonary Disease (COPD)"],"interventions":[{"type":"DRUG","name":"Roflumilast","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Roflumilast","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The aim of the study is to compare the efficacy of roflumilast on pulmonary function and symptomatic parameters in patients with chronic obstructive pulmonary disease (COPD) during concomitant administration of salmeterol. The study duration will last up to 28 weeks. The study will provide further data on safety and tolerability of roflumilast.","primaryOutcome":{"measure":"Pre-bronchodilator Forced Expiratory Volume in First Second (FEV1)","timeFrame":"Change from baseline over 24 weeks of treatment","effectByArm":[{"arm":"Roflumilast","deltaMin":39,"sd":9},{"arm":"Placebo","deltaMin":-10,"sd":9}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":1},"locations":{"siteCount":134,"countries":["Austria","Belgium","Canada","France","Germany","Italy","Netherlands","South Africa","Spain","United Kingdom"]},"refs":{"pmids":["19716961","20102307"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":36,"n":466},"commonTop":["Chronic obstructive pulmonary disease","Nasopharyngitis","Diarrhoea","Weight decreased","Nausea"]}}